Indicative valuation benchmarks for Indian SME and mid-market businesses — covering what EBITDA is, how multiples work, sector ranges, what moves your multiple up or down, and current M&A market trends.
The sector multiple ranges on this page are indicative benchmarks for educational purposes only — not formal valuation advice or guaranteed transaction outcomes. Consult a qualified CA, registered valuer, or investment banker before entering any transaction.
Most profitable Indian SMEs are valued in the broad range of 3× to 8× EBITDA, depending on sector, scale, growth, margins, customer concentration, management depth, governance quality, and buyer interest. For established, profitable SMEs with clean books and reasonable growth, the most common transaction range is 4×–6× EBITDA. Stronger businesses in pharma, healthcare, consumer brands, SaaS, specialised manufacturing, and renewable energy may command higher multiples. Smaller, founder-dependent, low-growth, or compliance-heavy businesses typically trade toward the lower end.
The EBITDA multiple should be treated as an indicative valuation benchmark, not a guaranteed transaction price. Final valuation depends on due diligence, deal structure, debt, working capital, tax impact, and competitive tension in the transaction process.
EBITDA stands for Earnings Before Interest, Tax, Depreciation and Amortisation. It measures operating profitability before the impact of financing costs, taxes, and non-cash accounting charges. In simple terms, EBITDA estimates what a business earns from its core operations before considering how it is financed, how it is taxed, and how assets are depreciated or amortised.
This makes EBITDA useful for comparing businesses of different sizes, debt levels, ownership structures, and asset intensity. Two businesses in the same sector with very different financing arrangements can be compared on a like-for-like basis once interest and tax are stripped out.
A Pune-based engineering components manufacturer reports the following:
The ₹6.3 crore EBITDA is the base on which a buyer would apply a sector multiple. At 5× EBITDA, the indicated Enterprise Value would be ₹31.5 crore. What the seller actually receives is a different number — covered in the Enterprise Value vs Equity Value section below.
EBITDA is a useful proxy for operating earnings but it is not the same as free cash flow. A business can show strong EBITDA and still generate weak cash if it has high receivables, long customer payment cycles, heavy inventory requirements, large annual maintenance capital expenditure, frequent machinery replacement, significant debt repayments, or outstanding tax and statutory obligations.
In practice, buyers move from EBITDA to a deeper review of cash conversion — how much of the reported EBITDA actually becomes cash in the business. A business with ₹5 crore EBITDA but ₹4 crore locked in overdue receivables is materially less attractive than a business of identical EBITDA with strong cash collection. For Indian SMEs specifically, receivables ageing and working capital cycles are frequently the source of the largest gap between reported EBITDA and actual cash generation.
| Term | What It Means | Why It Matters in a Transaction |
|---|---|---|
| EBITDA | Earnings Before Interest, Tax, Depreciation and Amortisation | The most commonly used base for valuing profitable Indian SMEs |
| EBITDA Multiple | The number by which EBITDA is multiplied to arrive at Enterprise Value | A 5× multiple on ₹5Cr EBITDA implies ₹25Cr Enterprise Value |
| Enterprise Value (EV) | Total value of the business before debt and cash adjustments | EBITDA multiple usually gives Enterprise Value, not what the seller receives |
| Equity Value | Enterprise Value minus net debt, subject to working capital and closing adjustments | Closer to what shareholders receive before tax and transaction costs |
| Net Debt | Total debt minus cash and cash equivalents | Deducted from EV to arrive at seller proceeds |
| Adjusted EBITDA | EBITDA after normalising genuine non-recurring or non-operational items | Often the most debated figure between buyer and seller |
| EBITDA Margin | EBITDA as a percentage of revenue | Higher margins typically support higher multiples; below 10% signals pricing pressure |
| EBIT | Earnings Before Interest and Tax — EBITDA minus depreciation and amortisation | Used less commonly for SME M&A; relevant for asset-light businesses |
| TTM / LTM EBITDA | Trailing or Last Twelve Months EBITDA | Used when recent performance differs materially from the last audited fiscal year |
| NTM EBITDA | Next Twelve Months — projected EBITDA | Sellers prefer NTM when growth is accelerating; buyers typically insist on LTM unless projections are highly credible |
| EV/EBITDA | Enterprise Value divided by EBITDA — the standard way of expressing a multiple | Used interchangeably with "EBITDA multiple" in M&A conversations |
| Revenue Multiple | Enterprise Value divided by revenue | Used when EBITDA is negative or not meaningful — common for SaaS and high-growth businesses |
| Asset-Based Valuation | Valuation based on net asset value rather than earnings | Relevant for distressed businesses, real estate-heavy operations, and asset-intensive manufacturing |
Once EBITDA is established, the multiple applied to it determines valuation. A business with ₹4 crore EBITDA valued at 5× has an Enterprise Value of ₹20 crore. The same business valued at 7× has an Enterprise Value of ₹28 crore. The EBITDA did not change. What changed was the buyer's assessment of business quality, growth potential, and risk.
This is why two companies in the same sector with the same EBITDA can receive different valuations. A company with long-term contracts, clean books, strong management depth, and diversified customers will usually command a higher multiple than a founder-dependent business with weak reporting and customer concentration. Understanding what drives the multiple — not just calculating the EBITDA — is the most important part of valuation preparation for an Indian SME owner.
"Every additional ₹1 crore of clean, recurring EBITDA demonstrated in the 12–18 months before a sale translates to ₹4–7 crore of additional Enterprise Value, depending on the multiple your sector commands. Preparation is the highest-return investment a seller can make."
An EBITDA multiple gives Enterprise Value — the total value of the business including debt. What a seller actually receives is the Equity Value, which is Enterprise Value minus net debt, adjusted for working capital and closing items, before tax and transaction costs.
Sellers should always clarify whether a valuation discussion is on an Enterprise Value basis or an Equity Value basis. A buyer discussing a "₹25 crore valuation" when the business carries ₹3 crore of bank debt means the seller receives approximately ₹22 crore — before tax, before transaction costs, and before any working capital adjustment at closing.
Even after Enterprise Value is agreed, the final payable amount typically adjusts for working capital. Most buyers expect the business to be delivered with a normal, sustainable level of working capital — sufficient inventory, reasonable receivables, and standard payables. If actual working capital at closing differs from an agreed baseline, the price adjusts accordingly.
A downward adjustment to the seller's proceeds may apply if receivables are old or doubtful, inventory is obsolete or slow-moving, payables have been unusually stretched to inflate cash, customer advances have been collected but the work remains pending, or GST, TDS, PF, ESIC, or other statutory dues are unpaid at closing.
For Indian SME sellers, the practical implication is that valuation should not be viewed only as EBITDA × Multiple. The full picture is: Enterprise Value, minus net debt, plus or minus working capital adjustment, minus taxes, minus transaction costs. Understanding this before entering a process prevents surprises at closing — when renegotiating is both difficult and damaging to trust.
EBITDA multiples are most commonly used in control transactions, where a buyer is acquiring a majority or full stake. Minority investments may be valued differently because the investor does not fully control cash flows, dividend decisions, management appointments, related-party transactions, exit timing, or strategic direction.
A buyer acquiring 100% of a business can treat EBITDA as its direct earnings claim. A minority investor must consider governance rights, exit options under the shareholders' agreement, dilution risk in future rounds, and the path to liquidity. A 5× EBITDA control valuation does not automatically mean a 20% minority stake will be valued at the same implied multiple — the governance framework, investor protections, and exit mechanics all feed into the minority valuation separately.
The tables below cover six broad categories — manufacturing and industrials, healthcare and pharma, technology and business services, consumer and food, logistics and energy, and financial services and education. The ranges are indicative benchmarks based on MergerDomo platform observations, advisor conversations, and publicly available market references adjusted for private-company scale and liquidity. Larger businesses within each category typically command the upper end of the range; smaller, founder-dependent businesses sit at the lower end.
| Sector | Indicative Range | Key Value Drivers |
|---|---|---|
| General manufacturing | 4× – 6× | Customer contracts, utilisation, asset condition, owner dependency, margin stability |
| Specialised / niche manufacturing | 5× – 8× | Proprietary processes, certifications, switching costs, export exposure |
| Engineering services | 4× – 6× | Repeat mandates, technical certifications, client diversity, design capability |
| Specialty chemicals | 5× – 9× | Product specialisation, compliance, customer stickiness, export mix |
| Auto ancillaries / precision components | 4× – 7× | OEM relationships, certifications, order visibility, capacity utilisation |
| Sector | Indicative Range | Key Value Drivers |
|---|---|---|
| Pharma — API / formulations | 6× – 10× | Product basket, DCGI/USFDA approvals, compliance, R&D, export exposure |
| Pharma distribution | 4× – 6× | Territory exclusivity, principal relationships, receivables quality |
| Hospitals and clinics | 5× – 9× | Occupancy, specialty mix, doctor retention, location, NABH accreditation |
| Diagnostics | 6× – 10× | Sample volume, brand, collection network, repeat demand |
| Sector | Indicative Range | Key Value Drivers |
|---|---|---|
| SaaS / software products | 4× – 8× EBITDA or 3× – 6× revenue | ARR growth, retention, churn, gross margin, CAC/LTV |
| IT services / staffing | 4× – 6× | Repeat clients, offshore delivery, client stickiness, attrition |
| Business services / outsourcing | 5× – 8× | Contractual revenue, retention, process depth, reduced founder dependency |
| Digital marketing / professional services | 3× – 6× | Retainers, team depth, IP-led delivery, founder dependence |
| Sector | Indicative Range | Key Value Drivers |
|---|---|---|
| FMCG / consumer brands | 6× – 12× | Brand strength, distribution reach, repeat purchase, margins |
| Food processing | 4× – 6× | FSSAI compliance, sourcing, capacity utilisation, shelf life |
| Organised retail | 4× – 7× | Same-store growth, lease terms, inventory turns, store profitability |
| D2C brands — high-growth, pre-profit | 3× – 6× revenue | Repeat purchase rate, CAC, contribution margin, brand recall |
| D2C brands — profitable | 4× – 7× EBITDA | Margin quality, customer retention, distribution, brand defensibility |
| Sector | Indicative Range | Key Value Drivers |
|---|---|---|
| Logistics and supply chain | 4× – 6× | Long-term contracts, fleet model, technology, client concentration |
| Renewable energy | 6× – 10× EBITDA (DCF and EV/MW also used) | PPA tenure, plant load factor, off-taker quality, asset life |
| Infrastructure services | 4× – 7× | Order book, working capital cycle, execution capability, dispute history |
| Sector | Indicative Range | Key Value Drivers |
|---|---|---|
| NBFCs / lending businesses | 1× – 3× book value (not EBITDA) | AUM quality, NPA levels, provisioning, capital adequacy |
| Real estate development | Asset / NAV / project cash flow-based | Approval status, inventory age, debt load, market absorption |
| Hospitality | 4× – 7× | Occupancy, ARR, RevPAR, location, brand affiliation |
| EdTech | 3× – 6× revenue (EBITDA-based if profitable) | Student retention, unit economics, CAC, brand |
| Educational institutions | 5× – 8× | Regulatory approvals, enrolment trends, real estate ownership, faculty stability |
| Agribusiness / agri-tech | 3× – 6× | Contract farming, processing capability, seasonal risk, supply chain control |
NBFCs and financial services: Valued on book value, P/E, or AUM quality rather than EBITDA. Loss-making businesses: Revenue multiples, GMV multiples, DCF, or asset-based methods are typically more relevant.
Across every sector above, there is a consistent relationship between deal size and the multiple commanded. A ₹2 crore EBITDA business will almost always attract a lower multiple than a ₹15 crore EBITDA business in the same sector, even if the smaller business is growing faster. This happens because the buyer universe is larger for bigger businesses, larger businesses carry more financial and management resilience, and the fixed costs of acquisition (legal, due diligence, integration) are spread over a larger earnings base — making each rupee of EBITDA more valuable to the buyer.
| EBITDA Size | Typical Buyer Universe | Valuation Implication |
|---|---|---|
| Below ₹1 Cr | Owner-operators, small strategics | Often difficult to value purely on EBITDA; asset or revenue approaches more common |
| ₹1 Cr – ₹3 Cr | Local strategic buyers, smaller investors | Usually lower end of sector range; limited PE interest at this size |
| ₹3 Cr – ₹10 Cr | Strategics, family offices, sector investors | Core Indian SME transaction range; broadening buyer universe |
| ₹10 Cr – ₹25 Cr | Larger strategics, family offices, select PE | Better competitive tension; PE begins to engage actively |
| Above ₹25 Cr | PE funds, larger corporates, cross-border buyers | Higher probability of premium multiple if quality and governance are strong |
The practical implication for sellers: building EBITDA from ₹2 crore to ₹4 crore before going to market may not only double the base — it may also improve the applicable multiple, producing a valuation that grows by more than the EBITDA increase alone would suggest.
Adjusted EBITDA — also called Normalised EBITDA — is EBITDA after removing genuine one-off, non-recurring, or non-operational items. This is one of the most debated aspects of any Indian SME transaction. Sellers want to add back expenses to show higher maintainable profitability. Buyers scrutinise every add-back to ensure it is real.
The general rule: if a new owner would realistically not incur the expense going forward, it may be a valid add-back. If the new owner must incur it to maintain the business at its current level, it is not.
In practice, sellers should document every add-back before approaching buyers — not assemble the list during negotiation. A well-documented, conservatively stated Adjusted EBITDA is far more credible than a number that keeps growing during the conversation.
According to PwC's Global M&A Industry Trends: 2026 Outlook, global deal values rose 36% in 2025 versus 2024, driven by approximately 600 transactions above US$1 billion — while the value across the remaining approximately 47,000 smaller transactions was flat year over year. The M&A market is described as increasingly K-shaped, favouring large, US-based, and technology-led deals. For Indian SMEs, the implication is clear: the global recovery in deal volumes and values is most visible at the large end. The mid-market and SME segment remains more selective, with buyers increasingly focused on quality — businesses with recurring revenue, management depth, and clean governance — rather than simply responding to availability.
Source: PwC Global M&A Industry Trends: 2026 Outlook — pwc.com/gx/en/services/deals/trends.html
PwC's Global M&A Trends in Industrials and Services: 2026 Outlook describes a market where geopolitical friction, labour scarcity, and supply chain shocks are driving companies to acquire automation, digital, and productivity-enhancing capabilities. In manufacturing specifically, portfolio reshaping, reshoring, and AI infrastructure demand are driving selective deals in automation, energy storage, and life-sciences-adjacent niches. For Indian SMEs in this space, the trend supports continued buyer interest in precision manufacturing, industrial automation suppliers, specialty chemicals, and B2B industrial services businesses — particularly those with strategic relevance to larger domestic or international acquirers. The PLI scheme has made Indian manufacturing strategically attractive, supporting multiples at the upper end of their sector ranges for well-run operators.
Source: PwC Global M&A Trends in Industrials and Services: 2026 Outlook — pwc.com/gx/en/services/deals/trends/industrials-services.html
Bain & Company's Global Healthcare Private Equity Report 2026 reports that global healthcare PE set a record in 2025, with an estimated $191 billion in deal value — surpassing the previous peak of 2021. Deal volume was similarly robust at 445 buyouts, the second-highest annual total on record, with biopharma and provider services accounting for the bulk of activity alongside continued growth in healthcare IT. For Indian healthcare SMEs, this global backdrop supports continued PE interest in diagnostics chains, specialty hospitals outside Tier 1 cities, pharma manufacturing and API businesses, and healthcare IT — though valuations remain dependent on India-specific factors including compliance standing, doctor and specialist retention, payer mix, expansion credibility, and occupancy trajectory.
Source: Bain & Company Global Healthcare Private Equity Report 2026 — bain.com/insights/topics/global-healthcare-private-equity-report/
PwC's Global M&A Trends in Technology, Media and Telecommunications: 2026 Outlook describes technology M&A as remaining a critical strategic lever, expressed through a broader range of transaction structures. Advances in model efficiency, financing conditions, and shifts in corporate priorities are influencing which companies transact and how deals are structured rather than reducing overall activity. For Indian technology businesses — SaaS, IT services, product engineering, and technology-enabled outsourcing — this supports continued deal activity, though buyers are increasingly focused on profitability metrics, client stickiness, and recurring revenue quality rather than growth at any cost. Businesses where the technology or process is proprietary and the customer relationships are contractual continue to attract the strongest interest.
Source: PwC Global M&A Trends in Technology, Media and Telecommunications: 2026 Outlook — pwc.com/gx/en/services/deals/trends/telecommunications-media-technology.html
After the liquidity-driven valuation environment of 2021–22, the Indian SME M&A market entered a more quality-driven phase through 2023–25. By 2026, buyer discipline has become the defining characteristic of the market. Businesses with scale, clean financials, recurring revenue, and management depth continue to attract interest and command competitive multiples. Smaller or founder-dependent businesses — particularly those with unresolved compliance gaps or declining margins — face significantly more difficult valuation conversations. The premium commanded by recurring revenue over transactional revenue has widened, and the discount applied to founder-dependent businesses has grown compared to five years ago, as the population of sophisticated buyers — PE funds, family offices, international acquirers — has increased. These observations are based on MergerDomo platform activity and advisor conversations and are not sourced from any single external dataset.
The EBITDA multiple ranges on this page are directional private-market benchmarks for Indian SMEs and mid-market businesses. They are not quoted market prices and should not be treated as guaranteed valuation outcomes or formal financial advice.
The ranges are based on a combination of MergerDomo platform observations across Indian SME sale, fundraising, and buyer or investor interest patterns; advisor conversations and transaction discussions in Indian SME and mid-market M&A; publicly available M&A, private equity, IPO, and sector trend reports; and listed-company trading multiples adjusted downward for private-company scale, liquidity, governance, and execution risk. Private SME transaction multiples in India are frequently confidential — most SME M&A deals do not publicly disclose EBITDA, transaction value, debt, working capital adjustment, or final equity value. Use these ranges as a starting point for discussion, not as a substitute for formal valuation.
This guide is for educational purposes only and does not constitute investment, legal, tax, accounting, or valuation advice. The sector multiple ranges are indicative benchmarks based on MergerDomo platform observations, advisor conversations, and publicly available market references — not guaranteed transaction outcomes. Actual valuation depends on business-specific due diligence, financial quality, deal structure, buyer interest, debt, working capital, compliance status, and market conditions. Private SME transaction multiples in India are frequently confidential — most deals do not publicly disclose EBITDA, transaction value, debt, working capital adjustment, or final equity value. Sellers and buyers should consult a qualified CA, IBBI-registered valuer, investment banker, tax advisor, or legal advisor before entering any transaction.
Use the free MergerDomo Valuation Tool for an indicative EBITDA-based range — then list your business confidentially to reach verified buyers, PE funds, and investors across 40+ sectors.